HETEROCYCLES SUBSTITUES LIES PAR FUSION EN TANT QUE MODULATEURS GPR119 POUR LE TRAITEMENT DU DIABETE, DE L'OBESITE, DE LA DYSLIPIDEMIE ET DE TROUBLES ASSOCIES
SCHWINK, LOTHAR,BUNING, CHRISTIAN,GLOMBIK, HEINER,GOSSEL, MATTHIAS,KADEREIT, DIETER,HALLAND, NIS,LOHMANN, MATTHIAS,POVERLEIN, CHRISTOPH,RITTER, KURT
申请号：
CA2942753
公开号：
CA2942753A1
申请日:
2015.04.02
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
